SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-063450
Filing Date
2021-05-10
Accepted
2021-05-10 08:07:39
Documents
13
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115704d1_8k.htm   iXBRL 8-K 28630
2 EXHIBIT 99.1 tm2115704d1_ex99-1.htm EX-99.1 98047
  Complete submission text file 0001104659-21-063450.txt   311793

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avdl-20210510.xsd EX-101.SCH 3181
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20210510_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20210510_pre.xml EX-101.PRE 22707
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2115704d1_8k_htm.xml XML 3473
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 21905314
SIC: 2834 Pharmaceutical Preparations